Published in Cancer Weekly, August 5th, 1996
Physicians are able to order OncorMed's BRCA2 test in combination with its already existing BRCA1 test, or as a separate service. The testing service is available to people at high risk for inherited breast cancer based on family history.
As with the company's BRCA1 and other cancer susceptibility testing services, the BRCA2 gene analysis is conducted under Institutional Review Board-approved protocols designed to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.